Gene · 540
Papers3,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A zinc metabolism-related gene signature for predicting prognosis and characteristics of breast cancer. | Front Immunol | 2023 | 38259456 | PubTator, text mining | PubMed |
| Recent Advances in Liver Tissue Engineering as an Alternative and Complementary Approach for Liver Transplantation. | Curr Issues Mol Biol | 2023 | 38248320 | PubTator, text mining | PubMed |
| Unexplained Chronic Liver Disease and Hemolytic Anemia in a Young Girl: A Case of Wilson's Disease. | Cureus | 2023 | 38234952 | PubTator, text mining | PubMed |
| Predictive Model of Oxaliplatin-induced Liver Injury Based on Artificial Neural Network and Logistic Regression. | J Clin Transl Hepatol | 2023 | 38161498 | PubTator, text mining | PubMed |
| Unravelling diagnostic clusters and immune landscapes of cuproptosis patterns in intervertebral disc degeneration through dry and wet experiments. | Aging (Albany NY) | 2023 | 38159257 | PubTator, text mining | PubMed |
| Potential impact of cuproptosis-related genes on tumor immunity in esophageal carcinoma. | Aging (Albany NY) | 2023 | 38159255 | PubTator, text mining | PubMed |
| Copper metabolism-related risk score identifies hepatocellular carcinoma subtypes and SLC27A5 as a potential regulator of cuproptosis. | Aging (Albany NY) | 2023 | 38157255 | PubTator, text mining | PubMed |
| Primary biliary cholangitis with features of autoimmune hepatitis in a 19-year-old adolescent with 14q24.1q24.2 deletion: a case report. | Front Pediatr | 2023 | 38152650 | PubTator, text mining | PubMed |
| Systematic analysis of Mendelian disease-associated gene variants reveals new classes of cancer-predisposing genes. | Genome Med | 2023 | 38143269 | PubTator, text mining | PubMed |
| The Specific Copper(II) Chelator TDMQ20 Is Efficient for the Treatment of Wilson's Disease in Mice. | Pharmaceutics | 2023 | 38140060 | PubTator, text mining | PubMed |
| Copper in Gynecological Diseases. | Int J Mol Sci | 2023 | 38139406 | PubTator, text mining | PubMed |
| Response of Fibroblasts from Menkes' and Wilson's Copper Metabolism-Related Disorders to Ionizing Radiation: Influence of the Nucleo-Shuttling of the ATM Protein Kinase. | Biomolecules | 2023 | 38136617 | PubTator, text mining | PubMed |
| Revisiting Genetic Influence on Mercury Exposure and Intoxication in Humans: A Scoping Review. | Toxics | 2023 | 38133368 | PubTator, text mining | PubMed |
| Novel cuproptosis-related lncRNAs can predict the prognosis of patients with multiple myeloma. | Transl Cancer Res | 2023 | 38130312 | PubTator, text mining | PubMed |
| Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma. | BMC Cancer | 2023 | 38114959 | PubTator, text mining | PubMed |
| The interplay between copper metabolism and microbes: in perspective of host copper-dependent ATPases ATP7A/B. | Front Cell Infect Microbiol | 2023 | 38106478 | PubTator, text mining | PubMed |
| Identification and validation of a seven cuproptosis-associated lncRNA signature to predict the prognosis of endometrial cancer. | J Int Med Res | 2023 | 38102991 | PubTator, text mining | PubMed |
| Copper-induced diurnal hepatic toxicity is associated with Cry2 and Per1 in mice. | Environ Health Prev Med | 2023 | 38092388 | PubTator, text mining | PubMed |
| CRISPR/Cas9 systems: Delivery technologies and biomedical applications. | Asian J Pharm Sci | 2023 | 38089835 | PubTator, text mining | PubMed |
| Two lncRNA signatures with cuproptosis as a novel prognostic model and clinicopathological value for endometrioid endometrial adenocarcinoma. | Aging (Albany NY) | 2023 | 38085674 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/540/papers?page=21